Uniphar’s acquisition of Irish-headquartered pharmacy solutions business NaviCorp is to be investigated by the Competition and Consumer Protection Commission .
The deals were expected to deliver a return on capital employed to the group in line with Uniphar’s target rate of 12-15 per cent within three years.
IrishTimes So what if the final incarnation refuses to deal with the government on pharmaceutical pricing?
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: businessposthq - 🏆 8. / 71 Read more »
Source: IrishTimesBiz - 🏆 6. / 77 Read more »